Skip to Content

Durect Corp DRRX

Morningstar Rating
$0.66 0.00 (0.46%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DRRX is trading at a 56% discount.
Price
$0.65
Fair Value
$3.48
Uncertainty
Extreme
1-Star Price
$11.53
5-Star Price
$5.24
Economic Moat
Vccxy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DRRX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.66
Day Range
$0.640.69
52-Week Range
$0.477.46
Bid/Ask
$0.64 / $0.69
Market Cap
$19.72 Mil
Volume/Avg
502,240 / 746,821

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.78
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
79

Valuation

Metric
DRRX
Price/Earnings (Normalized)
Price/Book Value
1.31
Price/Sales
1.78
Price/Cash Flow
Price/Earnings
DRRX

Financial Strength

Metric
DRRX
Quick Ratio
1.08
Current Ratio
1.19
Interest Coverage
−13.14
Quick Ratio
DRRX

Profitability

Metric
DRRX
Return on Assets (Normalized)
−58.62%
Return on Equity (Normalized)
−178.96%
Return on Invested Capital (Normalized)
−81.97%
Return on Assets
DRRX

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AYcbt$83.6 Bil
MKKGY
Merck KGaA ADRNkfvys$67.1 Bil
HLN
Haleon PLC ADRVhwq$37.9 Bil
VTRS
Viatris IncWmyx$11.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRZnlr$11.4 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRDpjk$11.3 Bil
CTLT
Catalent IncSljqg$6.8 Bil
PRGO
Perrigo Co PLCVfcg$4.0 Bil
EVO
Evotec SE ADRFxnm$3.7 Bil
CURLF
Curaleaf Holdings IncZrgt$3.2 Bil